Publication | Closed Access

Discovery of novel β-carboline-1,2,3-triazole hybrids as AChE/GSK-3β dual inhibitors for Alzheimer's disease treatment

Disease TreatmentAlzheimer's DiseaseMedicineRational Drug DesignPharmacological AgentAche/gsk-3β Dual InhibitorsPharmacotherapyNeurologyNovel β-Carboline-1,2,3-triazole HybridsDrug DevelopmentPharmacologyDrug Discovery